Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance

@inproceedings{Bender2013MineralocorticoidRV,
  title={Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance},
  author={Shawn B Bender and Adam Mcgraw and Iris Z Jaffe and James R Sowers},
  booktitle={Diabetes},
  year={2013}
}
Two-thirds of adults in the U.S. are overweight or obese, and another 26 million have type 2 diabetes (T2D). Patients with diabetes and/or the metabolic syndrome have a significantly increased risk of heart attack and stroke compared with people with normal insulin sensitivity. Decreased insulin sensitivity in cardiovascular tissues as well as in traditional targets of insulin metabolic signaling, such as skeletal muscle, is an underlying abnormality in obesity, hypertension, and T2D. In the… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 57 CITATIONS, ESTIMATED 47% COVERAGE

Vascular stiffness in insulin resistance and obesity

  • Front. Physiol.
  • 2015
VIEW 7 EXCERPTS
CITES BACKGROUND

Impact of DHA on Metabolic Diseases from Womb to Tomb

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2013
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Insulin resistance and hypertension

  • Molecular and Cellular Endocrinology
  • 1990
VIEW 5 EXCERPTS